Seattle Genetics, Inc. - Common Stock

$57.27 +$0.52 +0.91%

Shares Bought1
Shares Sold1
Shares Owned0
Last Price$57.27
Total Return-$0.01
Range Today$56.05 - $57.76
52 Week Range$45.31 - $71.31
Market Cap$8.16B
P/E Ratio-

Seattle Genetics, Inc. engages in the development and commercialization of monoclonal antibody-based therapies for cancer. Its product ADCETRIS, is an antibody-drug conjugate comprising an anti-CD30 monoclonal antibody attached by a protease-cleavable linker to a microtubule disrupting agent, monomethyl auristatin E. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA.

Open Positions

Buy Date Buy Price Quote Return $ Return % Owners

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners
10-02-17 17:09 10-05-17 18:38 $58.13 $58.12 -$0.01 -0.02% funkmasterflexion genovahero